Global harmonization of vaccine testing requirements: Making elimination of the ATT and TABST a concrete global achievement.

Clicks: 235
ID: 97238
2020
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
This one-day symposium organized by Humane Society International (HSI) brought together 18 international experts from Argentina, Brazil, China, Europe, India, Russia, South Africa and the United States to discuss the elimination of the abnormal toxicity test (ATT) from the testing requirements for human vaccines as well as the target animal batch safety test (TABST) and the laboratory animal batch safety test (LABST) for veterinary vaccines. Participants reported on country-specific regulatory requirements and, where present, the perspectives on waiver and elimination of those tests. In addition, the attendees, with HSI in the role of facilitator, moved to define the barriers to the complete elimination or waiving of these tests. This report expounds the outcomes of the symposium, and introduces a proposed roadmap - populated with country specific activities - for the elimination of these tests.
Reference Key
viviani2020globalbiologicals Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Viviani, Laura;Halder, Marlies;Gruber, Marion;Bruckner, Lukas;Cussler, Klaus;Sanyal, Gautam;Srinivas, Geetha;Goel, Sunil;Kaashoek, Marianne;Litthauer, Derek;Lopes da Silva, Arthur Leonardo;Sakanyan, Elena;Aprea, Patricia;Jin, Hongtao;Vandeputte, Joris;Seidle, Troy;Yakunin, Dimitriy;
Journal biologicals : journal of the international association of biological standardization
Year 2020
DOI
S1045-1056(19)30113-7
URL
Keywords
vaccines abnormal toxicity test batch release testing batch safety test target animal safety testing

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.